Crystal structure of Q4D6Q6, a conserved kinetoplastid-specific protein from Trypanosoma cruzi.


Journal

Journal of structural biology
ISSN: 1095-8657
Titre abrégé: J Struct Biol
Pays: United States
ID NLM: 9011206

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 23 02 2020
revised: 22 05 2020
accepted: 23 05 2020
pubmed: 31 5 2020
medline: 3 8 2021
entrez: 31 5 2020
Statut: ppublish

Résumé

Complete genome sequencing of the kinetoplastid protozoans Trypanosoma cruzi, Trypanosoma brucei and Leishmania major (Tritryp), published in 2005, opened up new perspectives for drug development targeting Chagas disease, African sleeping sickness and Leishmaniasis, neglected diseases affecting millions of most economically disadvantaged people. Still, half of the Tritryp genes code for proteins of unknown function. Moreover, almost 50% of conserved eukaryotic protein domains are missing in the Tritryp genomes. This suggests that functional and structural characterization of proteins of unknown function could reveal novel protein folds used by the trypanosomes for common cellular processes. Furthermore, proteins without homologous counterparts in humans may provide potential targets for therapeutic intervention. Here we describe the crystal structure of the T. cruzi protein Q4D6Q6, a conserved and kinetoplastid-specific protein essential for cell viability. Q4D6Q6 is a representative of a family of 20 orthologs, all annotated as proteins of unknown function. Q4D6Q6 monomers adopt a ββαββαββ topology and form a propeller-like tetramer. Oligomerization was verified in solution using NMR, SAXS, analytical ultra-centrifugation and gel filtration chromatography. A rigorous search for similar structures using the DALI server revealed similarities with propeller-like structures of several different functions. Although a Q4D6Q6 function could not be inferred from such structural comparisons, the presence of an oxidized cysteine at position 69, part of a cluster with phosphorylated serines and hydrophobic residues, identifies a highly reactive site and suggests a role of this cysteine as a nucleophile in a post-translational modification reaction.

Identifiants

pubmed: 32473201
pii: S1047-8477(20)30109-X
doi: 10.1016/j.jsb.2020.107536
pii:
doi:

Substances chimiques

Protozoan Proteins 0
kinetoplast-associated protein, protozoan 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107536

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Éverton Dias D'Andréa (ÉD)

Instituto de Bioquímica Médica Leopoldo de Meis, Instituto Nacional de Ciência e Tecnologia de Biologia Estrutural e Bioimagem, Centro Nacional de Ressonância Magnética Nuclear Jiri Jonas, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373 - sala E-32, 21941-902 Rio de Janeiro, RJ, Brazil.

Yvette Roske (Y)

Max-Delbrück Centrum für Molekulare Medizin, MDC, Robert-Rössle-Straβe 10, 13125 Berlin, Germany. Electronic address: yroske@mdc-berlin.de.

Guilherme A P de Oliveira (GAP)

Instituto de Bioquímica Médica Leopoldo de Meis, Instituto Nacional de Ciência e Tecnologia de Biologia Estrutural e Bioimagem, Centro Nacional de Ressonância Magnética Nuclear Jiri Jonas, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373 - sala E-32, 21941-902 Rio de Janeiro, RJ, Brazil.

Nils Cremer (N)

Leibniz-Institut für Molekulare Pharmakologie, FMP, Robert-Rössle-Straβe 10, 13125 Berlin, Germany.

Anne Diehl (A)

Leibniz-Institut für Molekulare Pharmakologie, FMP, Robert-Rössle-Straβe 10, 13125 Berlin, Germany.

Peter Schmieder (P)

Leibniz-Institut für Molekulare Pharmakologie, FMP, Robert-Rössle-Straβe 10, 13125 Berlin, Germany.

Udo Heinemann (U)

Max-Delbrück Centrum für Molekulare Medizin, MDC, Robert-Rössle-Straβe 10, 13125 Berlin, Germany; Freie Universität Berlin, Institut für Chemie und Biochemie, Takustrasse 3, 14195 Berlin, Germany.

Hartmut Oschkinat (H)

Leibniz-Institut für Molekulare Pharmakologie, FMP, Robert-Rössle-Straβe 10, 13125 Berlin, Germany; Freie Universität Berlin, Institut für Chemie und Biochemie, Takustrasse 3, 14195 Berlin, Germany.

José Ricardo Pires (JR)

Instituto de Bioquímica Médica Leopoldo de Meis, Instituto Nacional de Ciência e Tecnologia de Biologia Estrutural e Bioimagem, Centro Nacional de Ressonância Magnética Nuclear Jiri Jonas, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373 - sala E-32, 21941-902 Rio de Janeiro, RJ, Brazil. Electronic address: murari@bioqmed.ufrj.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH